khdc4 Antibody

What is KHDC4 and what cellular functions does it serve?

KHDC4 (KH domain containing 4, pre-mRNA splicing factor) is a protein involved in RNA metabolism and embryonic development. It plays a key role in regulation of gene expression and cell differentiation. Structurally, KHDC4 contains KH domains that enable RNA binding activity and contribute to mRNA splice site recognition. The protein is predicted to be part of the spliceosomal complex and is active primarily in the nucleus while also detected in the cytoplasm. KHDC4 is also known by alternative names including BLOM7, KIAA0907, and SNORA80EHG, which researchers should be aware of when conducting literature searches .

What types of KHDC4 antibodies are available for research?

Researchers can access several types of KHDC4 antibodies for experimental applications. Polyclonal antibodies, such as the KHDC4 Polyclonal Antibody (PACO37342), are produced in rabbits and demonstrate high specificity and sensitivity toward KHDC4 in human samples. These antibodies are typically generated using recombinant human KHDC4 protein fragments as immunogens, such as amino acids 1-241 of the human protein . Both non-conjugated and biotin-conjugated forms are available depending on the experimental design requirements. When selecting an antibody, researchers should verify species reactivity, which commonly includes human and mouse models, and confirm validation for specific applications like Western blotting, immunohistochemistry, and ELISA .

How are the structure and domains of KHDC4 relevant to antibody selection?

KHDC4 contains multiple functional domains that should influence antibody selection strategy:

Researchers should consider which domain is most relevant to their research question. Antibodies targeting different epitopes may yield different results depending on protein isoforms present in the experimental system. KHDC4 has multiple protein variants ranging from 450-572 amino acids in length, which may affect epitope accessibility and antibody recognition . For investigating specific functions, domain-specific antibodies may provide more precise results than those targeting the full-length protein.

What are the most common applications for KHDC4 antibodies?

KHDC4 antibodies are validated for several key applications in molecular and cellular research:

• Western blotting: Useful for detecting KHDC4 protein expression levels and identifying specific isoforms. The predicted band sizes for KHDC4 are 65, 60, 41, and 25 kDa, with the 65 kDa band most commonly observed in tissue samples like mouse liver .

• Immunohistochemistry (IHC): Enables visualization of KHDC4 localization within tissue sections, with successful application demonstrated in human tonsil tissue at dilutions of 1:100 .

• ELISA: Provides quantitative measurement of KHDC4 protein levels in various samples, with recommended dilution ranges of 1:2000-1:10000 .

• RNA splicing studies: Given KHDC4's role in pre-mRNA splicing, antibodies can be used in immunoprecipitation assays to identify RNA binding partners and splicing complexes.

What are the optimal conditions for using KHDC4 antibodies in Western blotting?

For optimal Western blotting results with KHDC4 antibodies, researchers should follow these methodological guidelines:

• Sample preparation: Cell or tissue lysates should be prepared in RIPA buffer supplemented with protease inhibitors to prevent protein degradation.

• Protein loading: 20-50 μg of total protein per lane is typically sufficient for detection.

• Dilution range: The recommended antibody dilution is 1:500-1:2000 for Western blotting applications .

• Detection system: Secondary antibodies conjugated to HRP (such as goat polyclonal anti-rabbit IgG) used at 1:10000 dilution provide good signal-to-noise ratio .

• Expected results: The predominant band should appear at approximately 65 kDa, though multiple bands may be observed due to different isoforms or post-translational modifications .

• Positive control: Mouse liver tissue has been validated as an appropriate positive control for KHDC4 detection .

How should researchers optimize immunohistochemistry protocols for KHDC4 detection?

Successful immunohistochemistry for KHDC4 requires careful protocol optimization:

• Fixation: 10% neutral buffered formalin is recommended for tissue fixation, with fixation time optimized to maintain antigen integrity.

• Antigen retrieval: Heat-induced epitope retrieval in citrate buffer (pH 6.0) improves antibody access to the epitope.

• Blocking: 5-10% normal serum (from the same species as the secondary antibody) reduces non-specific binding.

• Primary antibody: KHDC4 antibodies should be used at dilutions of 1:20-1:200 for IHC applications, with 1:100 being a good starting point based on validated results in human tonsil tissue .

• Incubation conditions: Overnight incubation at 4°C typically provides superior staining compared to shorter incubations at room temperature.

• Visualization system: DAB (3,3'-diaminobenzidine) substrates provide good contrast for KHDC4 detection in tissue sections.

What controls should be included when working with KHDC4 antibodies?

Proper experimental controls are critical for generating reliable data with KHDC4 antibodies:

• Positive control: Tissues or cell lines with known KHDC4 expression, such as mouse liver tissue for Western blotting or human tonsil tissue for IHC .

• Negative control: Omission of primary antibody while maintaining all other steps in the protocol helps identify non-specific binding of the secondary antibody.

• Isotype control: Using an irrelevant antibody of the same isotype (IgG) and concentration helps identify non-specific binding due to Fc receptor interactions .

• Knock-out/knock-down validation: While challenging to achieve with KHDC4 (as noted in research where KHDC4 was not efficiently suppressed compared to other targets), this represents the gold standard for antibody specificity verification .

• Peptide competition: Pre-incubation of the antibody with the immunizing peptide should eliminate specific staining and confirm antibody specificity.

How can KHDC4 antibodies be used to investigate RNA processing mechanisms?

KHDC4's role in RNA metabolism and splicing makes it an important target for studying RNA processing mechanisms:

• RNA-Protein Immunoprecipitation (RIP): KHDC4 antibodies can be used to pull down KHDC4-RNA complexes, followed by RNA extraction and sequencing to identify bound RNA species. This approach helps identify the RNA targets of KHDC4 in various cellular contexts.

• Chromatin Immunoprecipitation (ChIP) with RNA analysis: Since KHDC4 is involved in RNA splicing, researchers can use antibodies to investigate its association with nascent RNA transcripts and co-transcriptional splicing events.

• Immunofluorescence co-localization: KHDC4 antibodies can be used alongside markers of splicing speckles (e.g., SC35) to investigate KHDC4's dynamic localization during RNA processing events under various cellular conditions.

• Splicing factor complex analysis: Antibodies can help identify protein interactions within the spliceosomal complex through co-immunoprecipitation followed by mass spectrometry, providing insights into KHDC4's role in the splicing machinery .

• Cell fractionation studies: Nuclear and cytoplasmic fractions can be probed with KHDC4 antibodies to monitor the protein's distribution, potentially revealing shuttling behavior related to its RNA processing functions.

What experimental approaches can distinguish between different KHDC4 isoforms?

Distinguishing between KHDC4 isoforms requires specialized experimental approaches:

• Isoform-specific Western blotting: Multiple bands observed in Western blot (65, 60, 41, 25 kDa) likely represent different isoforms . Researchers should use gradient gels (4-15%) to achieve better separation of these variants.

• Domain-specific antibodies: Antibodies targeting specific domains present in some but not all isoforms can help distinguish variant expression patterns.

• 2D gel electrophoresis: Combining isoelectric focusing with SDS-PAGE followed by Western blotting can separate isoforms with similar molecular weights but different post-translational modifications.

• Mass spectrometry validation: Immunoprecipitation with KHDC4 antibodies followed by mass spectrometry analysis can identify specific peptides unique to each isoform.

• RNA analysis correlation: Correlating protein isoform detection with transcript variant analysis (by RT-PCR or RNA-seq) can provide comprehensive understanding of KHDC4 expression complexity .

How can KHDC4 antibodies be applied in developmental biology research?

Given KHDC4's involvement in embryonic development, several specialized applications are relevant:

• Developmental timing analysis: Immunohistochemistry or immunofluorescence with KHDC4 antibodies on embryonic tissue sections can reveal spatial and temporal expression patterns during development.

• Lineage tracing: Co-staining with lineage markers alongside KHDC4 can help identify cell populations where KHDC4 may play critical developmental roles.

• In vitro differentiation models: Monitoring KHDC4 expression changes during stem cell differentiation using Western blotting or immunofluorescence can reveal its role in cell fate decisions.

• Developmental knockout phenotyping: KHDC4 antibodies can help characterize phenotypes in KHDC4 knockout or conditional knockout models by assessing downstream effects on splicing patterns and gene expression.

• Embryo micro-injection experiments: Following targeted disruption of KHDC4 in embryonic models, antibodies can help assess the consequences on protein expression and localization.

How should researchers address inconsistent results when using KHDC4 antibodies?

Inconsistent results with KHDC4 antibodies may stem from several factors:

• Sample preparation variability: Ensure consistent protein extraction methods, as KHDC4 may be sensitive to different lysis buffers or extraction protocols.

• Antibody storage and handling: KHDC4 antibodies should be stored according to manufacturer recommendations (typically in 50% glycerol, 0.01M PBS, pH 7.4 with 0.03% Proclin 300 as preservative) at -20°C, avoiding repeated freeze-thaw cycles .

• Epitope masking: Post-translational modifications or protein-protein interactions may block antibody access to the epitope. Try different antigen retrieval methods or denaturing conditions.

• Batch-to-batch variability: Polyclonal antibodies may show variation between lots. Include positive controls from previous successful experiments when testing new antibody batches.

• Tissue or cell-specific effects: KHDC4 expression and isoform distribution may vary across tissues. Consider using tissue-matched positive controls when possible.

• Cross-reactivity assessment: Verify antibody specificity using knockout controls when available, although complete KHDC4 knockout has proven challenging in some experimental systems .

What strategies can improve signal-to-noise ratio when working with KHDC4 antibodies?

To optimize signal-to-noise ratio when using KHDC4 antibodies:

• Titration optimization: Test a range of antibody dilutions (1:500-1:2000 for WB, 1:20-1:200 for IHC) to find the optimal concentration that maximizes specific signal while minimizing background .

• Blocking optimization: Try different blocking agents (BSA, milk, normal serum) and concentrations (3-5%) to reduce non-specific binding.

• Incubation conditions: Longer incubations at lower temperatures (4°C overnight) often improve specificity compared to shorter incubations at room temperature.

• Washing stringency: Increase the number and duration of wash steps, possibly with higher detergent concentrations in wash buffers.

• Detection system selection: For weak signals, consider more sensitive detection methods like chemiluminescence with signal enhancement for Western blotting or tyramide signal amplification for IHC.

• Sample preparation refinement: Additional purification steps, such as subcellular fractionation, may improve detection of KHDC4 in specific compartments where it is more abundant.

How should researchers interpret multiple bands in Western blots using KHDC4 antibodies?

Multiple bands in KHDC4 Western blots require careful interpretation:

• Expected band pattern: KHDC4 antibodies typically detect bands at 65, 60, 41, and 25 kDa, with the 65 kDa band being the most prominent in tissues like mouse liver .

• Isoform consideration: The zebrafish KHDC4 has multiple protein isoforms ranging from 450-572 amino acids in length, suggesting human KHDC4 may also exist as several splice variants .

• Post-translational modifications: Phosphorylation, ubiquitination, or other modifications may alter protein migration, creating additional bands.

• Proteolytic processing: KHDC4 may undergo proteolytic cleavage during sample preparation or as part of its biological regulation, generating fragments detected by the antibody.

• Validation approach: To distinguish between specific and non-specific bands, researchers should compare patterns across multiple tissues, use peptide competition, and correlate with mRNA expression data.

How are KHDC4 antibodies being used to study RNA processing dysregulation in diseases?

KHDC4 antibodies offer valuable insights into RNA processing dysregulation in disease:

• Comparative expression analysis: Western blotting and IHC with KHDC4 antibodies enable comparison of expression levels between normal and diseased tissues, potentially revealing alterations in splicing regulation.

• Splicing factor complex alterations: Co-immunoprecipitation with KHDC4 antibodies followed by proteomic analysis can reveal changes in spliceosome composition in disease states.

• Altered cellular localization: Immunofluorescence with KHDC4 antibodies can detect abnormal subcellular distribution in disease models, indicating potential dysfunction.

• RNA processing effects: Combining KHDC4 immunoprecipitation with RNA-seq can identify disease-specific changes in KHDC4-associated transcripts and splicing patterns.

• Therapeutic target assessment: In models where RNA processing is dysregulated, monitoring KHDC4 expression and localization using antibodies may help evaluate potential therapeutic interventions targeting splicing mechanisms.

What is known about KHDC4's potential role in cancer research?

KHDC4's involvement in RNA metabolism and gene expression regulation suggests potential importance in cancer research:

• Expression analysis in tumors: KHDC4 antibodies can be used to assess protein expression in tumor versus normal tissue microarrays, potentially identifying correlations with cancer progression.

• Splicing alteration detection: Cancer cells often exhibit aberrant splicing patterns. KHDC4 antibodies can help investigate whether alterations in this splicing factor contribute to cancer-specific splice variants.

• Cell differentiation studies: Given KHDC4's role in cell differentiation, antibodies can help explore its function in cancer stem cell models and differentiation therapy approaches .

• Prognostic biomarker evaluation: Immunohistochemical analysis of KHDC4 in patient samples could be correlated with clinical outcomes to assess potential prognostic value.

• Therapeutic resistance mechanisms: Similar to studies examining IRF8's role in rituximab resistance, KHDC4 antibodies could help investigate whether this splicing factor influences response to cancer therapies .

Understanding KHDC4's function in cancer contexts may reveal new insights into RNA processing dysregulation as a driver of malignancy and potentially identify novel therapeutic targets in splicing regulatory pathways.